We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

Paradigm Biopharmaceuticals has appointed Advanced Clinical as its preferred CRO for the PARA_OA_012 phase III trial Advanced ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...

Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount Implemented in January - - GMP Site 1 Facility Complete and Certified for ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Designium Inc., a leading AR/XR studio, unveiled its new WebAR Template Service, aiming to transform the way businesses engage with customers through immersive digital experiences. As the demand for ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research ... during the trial, we recommend you report this transparently, with reasons. This sample size paragraph is intended to outline how ...

Background Uncertainty is defined as limited knowledge or lack of predictability about past, present or future events. The ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in ...